SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-176812
Filing Date
2024-07-09
Accepted
2024-07-09 17:25:19
Documents
45
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d736415d10q.htm   iXBRL 10-Q 650792
2 EX-31.1 d736415dex311.htm EX-31.1 10621
3 EX-31.2 d736415dex312.htm EX-31.2 10641
4 EX-32.1 d736415dex321.htm EX-32.1 3928
5 EX-32.2 d736415dex322.htm EX-32.2 3878
  Complete submission text file 0001193125-24-176812.txt   4287322

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acab-20240331.xsd EX-101.SCH 52185
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acab-20240331_cal.xml EX-101.CAL 21144
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acab-20240331_def.xml EX-101.DEF 261475
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acab-20240331_lab.xml EX-101.LAB 313183
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acab-20240331_pre.xml EX-101.PRE 290069
48 EXTRACTED XBRL INSTANCE DOCUMENT d736415d10q_htm.xml XML 490445
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Atlantic Coastal Acquisition Corp. II (Filer) CIK: 0001893219 (see all company filings)

IRS No.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41224 | Film No.: 241108163
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)